Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) EBT Margin (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of EBT Margin readings, the most recent being 1.63% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 162.0% to 1.63% in Q4 2025 year-over-year; TTM through Dec 2025 was 19.73%, a 996.0% decrease, with the full-year FY2025 number at 19.74%, down 997.0% from a year prior.
  • EBT Margin hit 1.63% in Q4 2025 for Tandem Diabetes Care, up from 10.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 5.29% in Q4 2021 to a low of 72.96% in Q1 2023.
  • Median EBT Margin over the past 5 years was 9.71% (2022), compared with a mean of 14.49%.
  • Biggest five-year swings in EBT Margin: plummeted -6364bps in 2023 and later surged 5234bps in 2024.
  • Tandem Diabetes Care's EBT Margin stood at 5.29% in 2021, then plummeted by -239bps to 7.33% in 2022, then crashed by -117bps to 15.91% in 2023, then soared by 100bps to 0.01% in 2024, then soared by 15240bps to 1.63% in 2025.
  • The last three reported values for EBT Margin were 1.63% (Q4 2025), 10.09% (Q3 2025), and 23.98% (Q2 2025) per Business Quant data.